Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Viridian Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 72
- +17 vs. Q4 2021
- Shares held
- 24.9M
- +1.67M (+7.2%) vs. Q4 2021
- Total value
- $460.9M
- +$1.09M (+0.2%) vs. Q4 2021
- New holders
- 20
- 24 more added
- Sold out
- 3
- 16 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GPS Wealth Strategies Group, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 222 | $4.00K | 0.00% | +209+1,607.7% | Added |
| Wells Fargo & Company | 311 | $5.00K | 0.00% | −175−36.0% | Reduced |
| Ovata Capital Management Ltd | 400 | $7.00K | 0.00% | +400 | New |
| Cutler Group LP | 1,550 | $28.0K | 0.00% | +1,550 | New |
| Tower Research Capital LLC (TRC) | 2,478 | $45.0K | 0.00% | +2,477+247,700.0% | Added |
| Dorsey Wright & Associates | 2,511 | $46.0K | 0.01% | +2,511 | New |
| Royal Bank of Canada | 6,937 | $128.0K | 0.00% | +6,937 | New |
| Gyon Technologies Capital Management, LP | 12,187 | $225.0K | 0.16% | +12,187 | New |
| Cannon Global Investment Management, LLC | 12,600 | $233.0K | 0.17% | +12,600 | New |
| PDT Partners, LLC | 14,390 | $266.0K | 0.02% | +1,775+14.1% | Added |
| Sciencast Management LP | 14,745 | $275.0K | 0.06% | +14,745 | New |
| Weiss Asset Management LP | 15,000 | $277.0K | 0.01% | +15,000 | New |
| Atom Investors LP | 16,106 | $298.0K | 0.14% | −2,778−14.7% | Reduced |
| Balyasny Asset Management LLC | 16,303 | $301.0K | 0.00% | +16,303 | New |
| Barclays PLC | 17,000 | $314.0K | 0.00% | +17,000 | New |
| Marshall Wace, LLP | 17,563 | $326.0K | 0.00% | −70,842−80.1% | Reduced |
| Bank of America Corp | 17,833 | $330.0K | 0.00% | +8,319+87.4% | Added |
| 683 Capital Management, LLC | 18,265 | $338.0K | 0.02% | −3,363−15.5% | Reduced |
| JPMorgan Chase & Co | 18,666 | $345.0K | 0.00% | +5,633+43.2% | Added |
| Ensign Peak Advisors, Inc | 21,405 | $396.0K | 0.00% | +21,405 | New |
| Bank of Montreal | 23,000 | $414.0K | 0.00% | +23,000 | New |
| HRT Financial LP | 24,092 | $445.0K | 0.00% | +24,092 | New |
| Maven Securities LTD | 27,486 | $508.0K | 0.11% | +5,535+25.2% | Added |
| Citigroup Inc | 28,140 | $520.0K | 0.00% | +13,256+89.1% | Added |
| Qube Research & Technologies Ltd | 33,187 | $614.0K | 0.01% | +16,187+95.2% | Added |
| Morgan Stanley | 34,929 | $646.0K | 0.00% | +21,234+155.0% | Added |
| HighVista Strategies LLC | 49,065 | $907.0K | 0.58% | +49,065 | New |
| Driehaus Capital Management LLC | 50,000 | $925.0K | 0.01% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 50,000 | $925.0K | 0.37% | +50,000 | New |
| LMR Partners LLP | 52,774 | $976.0K | 0.01% | +11,374+27.5% | Added |
| Northern Trust Corp | 56,487 | $1.04M | 0.00% | −2,841−4.8% | Reduced |
| Polar Asset Management Partners Inc. | 59,700 | $1.10M | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 61,390 | $1.14M | 0.01% | +61,390 | New |
| Jane Street Group, LLC | 61,518 | $1.14M | 0.00% | +61,518 | New |
| State Street Corp | 66,000 | $1.22M | 0.00% | +31,959+93.9% | Added |
| Goldman Sachs Group Inc | 66,598 | $1.23M | 0.00% | +66,598 | New |
| Endurant Capital Management LP | 83,217 | $1.54M | 0.46% | +15,767+23.4% | Added |
| Soleus Capital Management, L.P. | 90,000 | $1.66M | 0.26% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 90,072 | $1.67M | 0.21% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 97,527 | $1.80M | 0.00% | +97,527 | New |
| ExodusPoint Capital Management, LP | 97,745 | $1.81M | 0.03% | +20,988+27.3% | Added |
| Pura Vida Investments, LLC | 105,460 | $1.95M | 0.24% | +600+0.6% | Added |
| Silverarc Capital Management, LLC | 126,136 | $2.33M | 1.27% | +2,330+1.9% | Added |
| BlackRock Inc. | 152,775 | $2.83M | 0.00% | −351−0.2% | Reduced |
| Eversept Partners, LP | 155,743 | $2.88M | 0.27% | −38,846−20.0% | Reduced |
| Walleye Capital LLC | 162,281 | $3.00M | 0.09% | +52,106+47.3% | Added |
| Geode Capital Management, LLC | 199,238 | $3.68M | 0.00% | −2,440−1.2% | Reduced |
| Atlas Venture Advisors, Inc. | 209,505 | $3.87M | 0.83% | 00.0% | Unchanged |
| Woodline Partners LP | 221,257 | $4.09M | 0.07% | −36,413−14.1% | Reduced |
| Point72 Asset Management, L.P. | 300,000 | $5.55M | 0.02% | −172,864−36.6% | Reduced |
| Acuta Capital Partners, LLC | 340,000 | $6.29M | 2.99% | +22,000+6.9% | Added |
| Ghost Tree Capital, LLC | 466,403 | $8.62M | 4.27% | −33,597−6.7% | Reduced |
| Ally Bridge Group (NY) LLC | 496,012 | $9.17M | 6.80% | −108,762−18.0% | Reduced |
| Kynam Capital Management, LP | 589,826 | $10.9M | 3.55% | +301,892+104.8% | Added |
| Franklin Resources Inc | 600,023 | $11.1M | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 783,095 | $14.5M | 0.02% | +18,482+2.4% | Added |
| Vanguard Group Inc | 940,577 | $17.4M | 0.00% | +14,901+1.6% | Added |
| Citadel Advisors LLC | 941,218 | $17.4M | 0.02% | −2,122−0.2% | Reduced |
| Fairmount Funds Management LLC | 944,092 | $17.5M | 4.13% | 00.0% | Unchanged |
| Commodore Capital LP | 951,339 | $17.6M | 3.93% | +103,656+12.2% | Added |
| Millennium Management LLC | 975,618 | $18.0M | 0.02% | +513,228+111.0% | Added |
| Cormorant Asset Management, LP | 1,000,000 | $18.5M | 1.42% | +700,000+233.3% | Added |
| Avidity Partners Management LP | 1,040,000 | $19.2M | 0.43% | −238,261−18.6% | Reduced |
| Deep Track Capital, LP | 1,170,290 | $21.6M | 1.40% | −166,400−12.4% | Reduced |
| Paradigm Biocapital Advisors LP | 1,256,051 | $23.2M | 6.14% | +47,000+3.9% | Added |
| Vivo Capital, LLC | 1,300,000 | $24.0M | 1.66% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,314,000 | $24.3M | 9.75% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,423,053 | $26.3M | 0.55% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,739,530 | $32.2M | 2.74% | +1,739,530 | New |
| BVF Inc | 1,744,012 | $32.2M | 1.29% | −135,400−7.2% | Reduced |
| VR Adviser, LLC | 1,852,919 | $34.3M | 5.55% | 00.0% | Unchanged |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,505,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −21,512−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −12,216−100.0% | Sold out |